Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN37373664Phase 2Completed
Phase 2, randomised, double-blind trial in rotaviral diarrhea comparing RIX4414 vaccine with Placebo (2 arms). Primary endpoint: Seroconversion at visit 4. Started Jan 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN37373664.